These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17393954)

  • 1. Hepatosteatosis with hypobetalipoproteinemia.
    Sen D; Dagdelen S; Erbas T
    J Natl Med Assoc; 2007 Mar; 99(3):284-6. PubMed ID: 17393954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum.
    Tarugi P; Averna M
    Adv Clin Chem; 2011; 54():81-107. PubMed ID: 21874758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia.
    Katsuda S; Kawashiri MA; Inazu A; Tada H; Tsuchida M; Kaneko Y; Nozue T; Nohara A; Okada T; Kobayashi J; Michishita I; Mabuchi H; Yamagishi M
    Clin Chim Acta; 2009 Jan; 399(1-2):64-8. PubMed ID: 18848826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of fatty liver in familial hypobetalipoproteinemia linked to chromosome 3p21.
    Yue P; Tanoli T; Wilhelm O; Patterson B; Yablonskiy D; Schonfeld G
    Metabolism; 2005 May; 54(5):682-8. PubMed ID: 15877300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity.
    Tanoli T; Yue P; Yablonskiy D; Schonfeld G
    J Lipid Res; 2004 May; 45(5):941-7. PubMed ID: 14967820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A targeted apoB38.9 mutation in mice is associated with reduced hepatic cholesterol synthesis and enhanced lipid peroxidation.
    Lin X; Chen Z; Yue P; Averna MR; Ostlund RE; Watson MA; Schonfeld G
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1170-6. PubMed ID: 16455790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (APO B-54.5).
    Tarugi P; Lonardo A; Ballarini G; Erspamer L; Tondelli E; Bertolini S; Calandra S
    J Hepatol; 2000 Sep; 33(3):361-70. PubMed ID: 11019990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Liver steatosis, insulin resistance and hypobetalipoproteinemia].
    Núñez Martínez O; Pajares Villarroya R; Olivar Roldán J; Manceñido Marcos N; Erdozaín Sosa JC
    Gastroenterol Hepatol; 2013; 36(7):457-8. PubMed ID: 23537751
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis.
    Schonfeld G; Patterson BW; Yablonskiy DA; Tanoli TS; Averna M; Elias N; Yue P; Ackerman J
    J Lipid Res; 2003 Mar; 44(3):470-8. PubMed ID: 12562873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemia.
    Whitfield AJ; Marais AD; Robertson K; Barrett PH; van Bockxmeer FM; Burnett JR
    Hum Mutat; 2003 Aug; 22(2):178. PubMed ID: 12872264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent familial hypobetalipoproteinemia-induced nonalcoholic fatty liver disease after living donor liver transplantation.
    Harada N; Soejima Y; Taketomi A; Yoshizumi T; Uchiyama H; Ikegami T; Saibara T; Nishizaki T; Maehara Y
    Liver Transpl; 2009 Jul; 15(7):806-9. PubMed ID: 19562718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Homozygous familial hypobetalipoproteinemia caused by APOB gene variations: a case report and review of literature].
    Zhang YQ; Wang JS
    Zhonghua Er Ke Za Zhi; 2023 Jan; 61(1):70-75. PubMed ID: 36594125
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatty liver in a case with heterozygous familial hypobetalipoproteinemia.
    Ogata H; Akagi K; Baba M; Nagamatsu A; Suzuki N; Nomiyama K; Fujishima M
    Am J Gastroenterol; 1997 Feb; 92(2):339-42. PubMed ID: 9040220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E and oxidative stress in abetalipoproteinemia and familial hypobetalipoproteinemia.
    Burnett JR; Hooper AJ
    Free Radic Biol Med; 2015 Nov; 88(Pt A):59-62. PubMed ID: 26086616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric gallstone disease in familial hypobetalipoproteinemia.
    Lancellotti S; Zaffanello M; Di Leo E; Costa L; Lonardo A; Tarugi P
    J Hepatol; 2005 Jul; 43(1):188-91. PubMed ID: 15894400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of tocopherol metabolism and oxidative stress in familial hypobetalipoproteinemia.
    Clarke MW; Hooper AJ; Headlam HA; Wu JH; Croft KD; Burnett JR
    Clin Chem; 2006 Jul; 52(7):1339-45. PubMed ID: 16728468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hypobetalipoproteinemia in a hospital survey: genetics, metabolism and non-alcoholic fatty liver disease.
    Gutiérrez-Cirlos C; Ordóñez-Sánchez ML; Tusié-Luna MT; Patterson BW; Schonfeld G; Aguilar-Salinas CA
    Ann Hepatol; 2011; 10(2):155-64. PubMed ID: 21502677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia.
    Di Filippo M; Moulin P; Roy P; Samson-Bouma ME; Collardeau-Frachon S; Chebel-Dumont S; Peretti N; Dumortier J; Zoulim F; Fontanges T; Parini R; Rigoldi M; Furlan F; Mancini G; Bonnefont-Rousselot D; Bruckert E; Schmitz J; Scoazec JY; Charrière S; Villar-Fimbel S; Gottrand F; Dubern B; Doummar D; Joly F; Liard-Meillon ME; Lachaux A; Sassolas A
    J Hepatol; 2014 Oct; 61(4):891-902. PubMed ID: 24842304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatic steatosis associated with heterozygotic familial hypobetalipoproteinemia].
    Alapont Puchalt B; Prósper Sierra M; Ricart Alvarez E; Navarro Hervás M
    Gastroenterol Hepatol; 2004 Apr; 27(4):256-9. PubMed ID: 15056412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutations in SAR1B and MTTP genes in Tunisian children with chylomicron retention disease and abetalipoproteinemia.
    Magnolo L; Najah M; Fancello T; Di Leo E; Pinotti E; Brini I; Gueddiche NM; Calandra S; Slimene NM; Tarugi P
    Gene; 2013 Jan; 512(1):28-34. PubMed ID: 23043934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.